CTLA-4 (CD152) blockade does not cause a pro-inflammatory cytokine profile in regulatory T cells

Clinical and Experimental Rheumatology

Volumn 29, Issue 2, 2011, Pages 254-260

  Kolar, P ^a,b   Hoff, H ^a,b   Maschmeyer, P ^a,b,c   Burmester, G R ^b   Brunner Weinzierl, Monika C ^a,b,d  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^d UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Co stimulation; CTLA 4; Cytokines; Regulatory T cell

Indexed keywords

CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; CYTOKINE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HELPER CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; CELL CULTURE; CELL DIVISION; CYTOLOGY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISEASE; MOUSE MUTANT;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; CELL DIVISION; CELLS, CULTURED; CYTOKINES; IMMUNOPHENOTYPING; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 79959520943     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. KOLAR P, KNIEKE K, HEGEL JK et al.: CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum 2009; 60: 123-32.
2. TAKAHASHI T, TAGAMI T, YAMAZAKI S et al.: Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyteassociated antigen 4. J Exp Med 2000; 192: 303-10.
3. WALUNAS TL, BAKKER CY, BLUESTONE JA: CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 1996; 183: 2541-50.
4. WALUNAS TL, LENSCHOW DJ, BAKKER CY et al.: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-13.
5. MASZYNA F, HOFF H, KUNKEL D, RADBRUCH A, BRUNNER-WEINZIERL MC: Diversity of clonal T cell proliferation is mediated by differential expression of CD152 (CTLA-4) on the cell surface of activated individual T lymphocytes. J Immunol 2003; 171: 3459-66.
6. HARPER K, BALZANO C, ROUVIER E, MATTEI MG, LUCIANI MF, GOLSTEIN P: CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991; 147: 1037-44.
7. PENTCHEVA-HOANG T, EGEN JG, WOJNOONSKI K, ALLISON JP: B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004; 21: 401-13.
8. KARANDIKAR NJ, VANDERLUGT CL, WALUNAS TL, MILLER SD, BLUESTONE JA: CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996; 184: 783-8.
9. CHAMBERS CA, KRUMMEL MF, BOITEL B et al.: The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 1996; 153: 27-46.
10. BRUNNER MC, CHAMBERS CA, CHAN FK, HANKE J, WINOTO A, ALLISON JP: CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol 1999; 162: 5813-20.
11. GROHMANN U, ORABONA C, FALLARINO F et al.: CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3: 1097-101.
12. MUNN DH, SHARMA MD, MELLOR AL: Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 23-dioxygenase activity in dendritic cells. J Immunol 2004; 172: 4100-10.
13. FALLARINO F, GROHMANN U, HWANG KW et al.: Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4: 1206-12.
14. WATERHOUSE P, BACHMANN MF, PENNINGER JM, OHASHI PS, MAK TW: Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur J Immunol 1997; 27: 1887-92.
15. TIVOL EA, BORRIELLO F, SCHWEITZER AN, LYNCH WP, BLUESTONE JA, SHARPE AH: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-7.
16. CHAMBERS CA, SULLIVAN TJ, ALLISON JP: Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 1997; 7: 885-95.
17. WATERHOUSE P, PENNINGER JM, TIMMS E et al.: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985-8.
18. GARTNER D, HOFF H, GIMSA U, BURMESTER GR, BRUNNER-WEINZIERL MC: CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on longterm disease progression. J Neuroimmunol 2006; 172: 73-84.
19. ISE W, KOHYAMA M, NUTSCH KM et al.: CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol 2010; 11: 129-35.
20. UEDA H, HOWSON JM, ESPOSITO L et al.: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-11.
21. FEHERVARI Z, SAKAGUCHI S: A paragon of self-tolerance: CD25+CD4+ regulatory T cells and the control of immune responses. Arthritis Res Ther 2004; 6: 19-25.
22. FEHERVARI Z, SAKAGUCHI S: Development and function of CD25+CD4+ regulatory T cells. Curr Opin Immunol 2004; 16: 203-8.
23. SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
24. CHEN W, JIN W, HARDEGEN N et al.: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGFbeta induction of transcription factor Foxp3. J Exp Med 2001; 198: 1875-86.
25. ZHENG SG, WANG JH, STOHL W, KIM KS, GRAY JD, HORWITZ DA: TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J Immunol 2006; 176: 3321-9.
26. TANG Q, BODEN EK, HENRIKSEN KJ, BOUR-JORDAN H, BI M, BLUESTONE JA: Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur J Immunol 2004; 34: 2996-3005.
27. READ S, MALMSTROM V, POWRIE F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302.
28. KINGSLEY CI, KARIM M, BUSHELL AR, WOOD KJ: CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-6.
29. RILEY JL, JUNE CH, BLAZAR BR: Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009; 30: 656-65.
30. ZHOU X, BAILEY-BUCKTROUT SL, JEKER LT et al.: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10: 1000-7.
31. WING K, ONISHI Y, PRIETO-MARTIN P et al.: CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271-5.
32. FRIEDLINE RH, BROWN DS, NGUYEN H et al.: CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009; 206: 421-34.
33. SARNAIK AA, WEBER JS: Recent advances using anti-CTLA-4 for the treatment of melanoma. Cancer J 2009; 15: 169-73.
34. HOFF H, KOLAR P, AMBACH A, RADBRUCH A, BRUNNER-WEINZIERL MC: CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch. Mol Immunol; 47: 1875-81.